NO903360L - Antibiotiske forbindelser. - Google Patents

Antibiotiske forbindelser.

Info

Publication number
NO903360L
NO903360L NO90903360A NO903360A NO903360L NO 903360 L NO903360 L NO 903360L NO 90903360 A NO90903360 A NO 90903360A NO 903360 A NO903360 A NO 903360A NO 903360 L NO903360 L NO 903360L
Authority
NO
Norway
Prior art keywords
antibiotic compounds
formula
ring
coch2
cleavable
Prior art date
Application number
NO90903360A
Other languages
English (en)
Norwegian (no)
Other versions
NO903360D0 (no
Inventor
Laurent Francois And Hennequin
David Michael Hollinshead
Original Assignee
Ici Pharma
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Pharma, Ici Plc filed Critical Ici Pharma
Publication of NO903360D0 publication Critical patent/NO903360D0/no
Publication of NO903360L publication Critical patent/NO903360L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO90903360A 1989-08-11 1990-07-30 Antibiotiske forbindelser. NO903360L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89402289 1989-08-11

Publications (2)

Publication Number Publication Date
NO903360D0 NO903360D0 (no) 1990-07-30
NO903360L true NO903360L (no) 1991-02-12

Family

ID=8202985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903360A NO903360L (no) 1989-08-11 1990-07-30 Antibiotiske forbindelser.

Country Status (11)

Country Link
US (1) US5219848A (fr)
EP (1) EP0412763B1 (fr)
JP (1) JPH03128384A (fr)
AT (1) ATE140230T1 (fr)
AU (1) AU6014390A (fr)
CA (1) CA2022664A1 (fr)
DE (1) DE69027718T2 (fr)
FI (1) FI903963A0 (fr)
NO (1) NO903360L (fr)
PT (1) PT94959A (fr)
ZA (1) ZA906060B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215982A (en) * 1989-11-10 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
SK3795A3 (en) * 1993-04-13 1995-05-10 Ciba Geigy Ag Derivatives of branched aminooxyaminoalkane inhibiting the orniting decarboxylasts, pharmaceutical agent containing them and method of their production
CN102040615B (zh) * 2009-10-12 2012-12-26 山东轩竹医药科技有限公司 含有二氢吡咯并环烷基的头孢抗生素
MX352760B (es) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Metodos para tratar infecciones intrapulmonares.
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52119885A (en) * 1976-04-01 1977-10-07 Sony Corp Gas laser tube
US4278733A (en) * 1979-07-23 1981-07-14 Spaulding Fibre Company, Inc. Epoxy modified aniline-phenolic laminate
US4855420A (en) * 1983-06-03 1989-08-08 Ici Pharma Cephalosporin derivatives
DE3581891D1 (de) * 1984-11-12 1991-04-04 Banyu Pharma Co Ltd Cephalosporinderivate.
ES8704943A1 (es) * 1984-12-27 1987-04-16 Banyu Pharma Co Ltd Un procedimiento para la fabricacion de derivados de cefalosporina.
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4728734A (en) * 1985-11-25 1988-03-01 American Home Products Corporation C-3'thioiminosulfonyl cephalosporin analogs
US4728733A (en) * 1985-11-25 1988-03-01 American Home Products Corporation C-3' thiadiazinyl cephalosporin analogs
US4728732A (en) * 1985-11-25 1988-03-01 American Home Products Corporation C-3'acylsulfonamido cephalosporin analogs
GB8611823D0 (en) * 1986-05-15 1986-06-25 Ici Plc Process
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
EP0269298B1 (fr) * 1986-11-21 1994-10-19 Ici Pharma Céphalosporines, leur procédé de préparation et compositions pharmaceutiques

Also Published As

Publication number Publication date
CA2022664A1 (fr) 1991-02-12
AU6014390A (en) 1991-02-14
EP0412763A2 (fr) 1991-02-13
ZA906060B (en) 1991-05-29
PT94959A (pt) 1991-05-22
DE69027718D1 (de) 1996-08-14
JPH03128384A (ja) 1991-05-31
ATE140230T1 (de) 1996-07-15
EP0412763A3 (en) 1992-03-04
US5219848A (en) 1993-06-15
DE69027718T2 (de) 1996-12-05
EP0412763B1 (fr) 1996-07-10
NO903360D0 (no) 1990-07-30
FI903963A0 (fi) 1990-08-10

Similar Documents

Publication Publication Date Title
NO903360D0 (no) Antibiotiske forbindelser.
AU6889294A (en) Novel intermediates useful in the preparation of heteroaroyl derivatives of monocyclic beta-lactam antibiotics
ATE113953T1 (de) Cephalosporine, verfahren zu ihrer herstellung und pharmazeutische präparate.
ATE130299T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische präparate.
ES2061724T3 (es) Derivados de sacarido.
ES2096572T3 (es) Nuevos derivados de glucosidos de antraciclina y procedimiento para su preparacion.
ES2064440T3 (es) Cefalosporinas, proceso para su preparacion, intermedios y composiciones farmaceuticas.
NZ222015A (en) 7-(meta-substituted phenylglycine)-1-carba-1-dethiacephalsporins and pharmaceutical compositions
ES2077345T3 (es) Intermediarios del grupo mureidomicina, su preparacion y su uso.
DE3662270D1 (en) Anthracycline compounds, a process for their preparation and their use as medicaments
GB9112831D0 (en) Preparation of polycyclic dyes
IL90172A0 (en) 2,3-dihydro-imidazo(1,2-a)furo and-thieno pyridine derivatives,their preparation and pharmaceutical compositions containing them